HEALTH

GSK Consumer Healthcare CEO in line to succeed GSK CEO Andrew Witty

BY Michael Johnsen

LONDON — GSK on Tuesday named Emma Walmsley GSK CEO Designate and successor to Andrew Witty as GSK CEO when he retires on March 31, 2017. She will join the GSK board of directors on Jan. 1, 2017.

"Emma is an outstanding leader with highly valuable experience of building and running major global businesses and a strong track record of delivering growth and driving performance in healthcare," stated Philip Hampton, GSK chairman. "Under Andrew’s leadership, GSK has successfully developed into a company with market-leading positions in pharmaceuticals, vaccines and consumer healthcare.  These provide excellent platforms for sustainable, long-term growth, and we are confident Emma will successfully build on these strengths.”

“I am delighted and honoured to be appointed GSK’s next CEO," Walmsley said. "GSK is a company that leads both in science and in the way it does business. We have momentum in the Group and as the demand for medical innovation and trusted healthcare products continues to rise, we have the opportunity and the potential to create meaningful benefits for patients, consumers and our shareholders. I’m looking forward to working with Andrew and other leaders over the next few months to ensure a smooth handover and to develop plans for 2017 and beyond.”

Walmsley is currently CEO of GSK's Consumer Healthcare division.

Prior to this, Emma was president of GSK Consumer Healthcare and has been a member of GSK’s corporate executive team since 2011.  Emma joined GSK in 2010 from L’Oreal where, over the course of her 17-year career, she held a variety of marketing and general management roles in the U.K., Europe and U.S. From 2007 she was based in Shanghai as general manager, consumer products for L’Oreal China.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

HRG to lead panel discussion on self-care white paper at GMDC HBW16

BY Michael Johnsen

WAUKESHA, Wis. – Hamacher Resource Group will be among the keynote speakers at the Home Health Business Session next week during the Global Market Development Center Health, Beauty, and Wellness Marketing Conference (HBW16).

Dave Wendland, VP strategic relations and member of the owners group at HRG, will lead the panel discussion of the secondary research HRG completed for GMDC that is featured in the recently released paper, “Home Health: Preparing for the Future of Retail Health Care.”

The keynote speakers and panelists will examine the combination of factors that has patients and
family caregivers dealing with more health issues themselves, furthering downstream innovation and consumer selfcare. Within the context of the transition to consumer-led care, they will explore the opportunities for all trading partners in the retail environment.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Garden of Life obtains NSF International certification

BY Michael Johnsen

PALM BEACH GARDENS, Fla. – Garden of Life announced Tuesday that it has obtained NSF International certification of the contents and label claims for mykind Organics, a multivitamin sold primarily through the specialty channel, including Vitamin Shoppe and Whole Foods.

"Mykind Organics is truly unique as the only vitamin line to hold an extensive list of independent certifications, which assure fans of the products' integrity and quality," stated Brian Ray, president Garden of Life. "It took years of innovation and patience to develop the line. Mykind Organics multis are the first line of Certified USDA Organic, Non-GMO Project Verified, Vegan and Gluten-Free Certified multivitamins combining vitamins and minerals created from organic plants, rather than synthetic chemicals. With the new NSF International certification, mykind Organics is leading the charge in dietary supplement traceability, transparency and quality."

Garden of Life introduced mykind Organics multivitamins in 2014 as a complete line, including vitamins for women and men, prenatal multivitamins and multivitamins specifically formulated for men and women over 40 years old. Working in a unique collaboration with actress, New York Times best-selling author and well-known vegan health expert, Alicia Silverstone, Garden of Life brought a formula to market where every offering is Certified Organic, Verified Non-GMO by the Non-GMO Project, Certified Gluten Free, Vegan and Kosher.

NSF International's dietary supplement testing and certification program has three key components: Good Manufacturing Practices registration, NSF International dietary supplement certification and NSF Certified for Sport certification. Manufacturing facilities must pass twice-annual audits to earn entry-level GMP registration before they can move on to earn NSF International's dietary supplement product/ingredient certification. The dietary supplement certification process includes label claim, toxicology and contaminant reviews, with ongoing monitoring to verify compliance through periodic auditing and testing.

"Dietary supplements have come under intense scrutiny over the past few years as attorneys general from some states, news outlets and industry watchdogs have called in to question the integrity of certain products sold in various mass-retail outlets," said Cheryl Luther, general manager, dietary supplements/sports nutrition/beverage quality at NSF International. "Today, dietary supplements are produced from a complicated, global supply chain, making it essential that quality manufacturers test not only their finished products, but also their raw ingredients, ensuring both their safety and quality. We are pleased to be working so closely with Garden of Life."
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?